These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation. Giry K, Péan JM, Giraud L, Marsas S, Rolland H, Wüthrich P. Int J Pharm; 2006 Sep 14; 321(1-2):162-6. PubMed ID: 16797150 [Abstract] [Full Text] [Related]
4. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate. Le VN, Bierend H, Robins E, Steckel H, Flament MP. Int J Pharm; 2012 Jan 17; 422(1-2):75-82. PubMed ID: 22036653 [Abstract] [Full Text] [Related]
5. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler. de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW. Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246 [Abstract] [Full Text] [Related]
6. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development. Le VN, Robins E, Flament MP. Eur J Pharm Biopharm; 2010 Nov 09; 76(3):464-9. PubMed ID: 20854906 [Abstract] [Full Text] [Related]
7. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Zeng XM, MacRitchie HB, Marriott C, Martin GP. Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863 [Abstract] [Full Text] [Related]
8. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design. Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G. Int J Pharm; 2009 Oct 01; 380(1-2):80-8. PubMed ID: 19596428 [Abstract] [Full Text] [Related]
13. Effect of milling and sieving on functionality of dry powder inhalation products. Steckel H, Markefka P, teWierik H, Kammelar R. Int J Pharm; 2006 Feb 17; 309(1-2):51-9. PubMed ID: 16377105 [Abstract] [Full Text] [Related]
14. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations. Marriott C, MacRitchie HB, Zeng XM, Martin GP. Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848 [Abstract] [Full Text] [Related]
15. Effect of carrier particle shape on dry powder inhaler performance. Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A. Int J Pharm; 2011 Dec 12; 421(1):12-23. PubMed ID: 21945739 [Abstract] [Full Text] [Related]
17. Dry powders for oral inhalation free of lactose carrier particles. Healy AM, Amaro MI, Paluch KJ, Tajber L. Adv Drug Deliv Rev; 2014 Aug 12; 75():32-52. PubMed ID: 24735676 [Abstract] [Full Text] [Related]
18. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method. You Y, Zhao M, Liu G, Tang X. J Pharm Pharmacol; 2007 Jul 12; 59(7):927-34. PubMed ID: 17637186 [Abstract] [Full Text] [Related]